Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UPDATE 2-European shares follow Wall Street higher on recovery hopes

Published 20/05/2020, 18:10
Updated 20/05/2020, 18:12
© Reuters.

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* Tech rally on Wall Street spreads to Europe
* Marks & Spencer rises on turnaround plan
* AstraZeneca gains after U.S. FDA nod for Lynparza

(Updates to market close)
By Sruthi Shankar
May 20 (Reuters) - European shares swung higher on Wednesday
as hopes of a rebound from a coronavirus-led economic slump
charged Wall Street and technology stocks rose on both sides of
the Atlantic.
The pan-European STOXX 600 .STOXX finished 1% higher after
falling as much as 0.8% at the open. The euro zone's leading
stocks index .STOXX50E gained 1.4%.
An upbeat start for Wall Street after record gains for
Facebook FB.O and Amazon.com Inc AMZN.O sent European stocks
to their strongest close in three weeks. .N
Technology stocks .SX8P led the European gains with a 2.2%
jump, while chemicals .SX4P and oil & gas .SXEP rose 1.7%
each, helping reverse early losses on recurrent doubts over a
potential coronavirus vaccine.
"This buoyant start gave a helping hand to the European
indices, which had initially been flagging," wrote Connor
Campbell, a financial analyst at SpreadEx.
Another boost to the STOXX 600 was AstraZeneca Plc AZN.L ,
which gained 2.4% after U.S. regulators approved Merck Inc's
MRK.N and its Lynparza as a prostate cancer treatment.
British retailer Marks & Spencer MKS.L jumped 10.8% after
saying it would accelerate its latest turnaround programme.
A stock market recovery from March lows has stalled, with
the STOXX 600 up 0.8% this month after a 6% jump in April.
"Investors are playing a waiting game," said Edmund Shing,
global head of equity derivatives strategy at BNP Paribas. "We
want to see how the exit from lockdowns proceeds and see how
quickly each economy picks up."
European markets have cheered a Franco-German proposal for a
500 billion-euro Recovery Fund that would bind all 27 European
Union states to raise debt jointly to offer grants to regions
hit hardest.
However, Austrian Chancellor Sebastian Kurz said on Tuesday
a group of EU states will propose loans, not grants.
The world's biggest credit data company Experian Plc
EXPN.L gained 7.4% as it said its executive directors would
take a 25% salary cut for six months and forecast first-quarter
organic revenue to decline by 5% to 10%. German business software group SAP SAPG.DE rose 2% after a
company executive said it expects to stick to its dividend
policy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.